Axelle De BruyneClinical Trials Transparency and Disclosure Lead at ArgenxSpeaker
Profile
Axelle De Bruyne is the clinical trial transparency and disclosure lead at argenx. She was introduced to protocol registration and result posting 5 years ago as a regulatory liaison. To keep up with the increased and fast changing global transparency requirements, she established a clinical trials transparency and disclosure team within the organization last year. She is currently leading the disclosure activities such as protocol registration, result posting as well as the redaction and anonymization of submission documents while establishing new transparency procedures.
Agenda Sessions
CASE STUDY Navigating a First-Time Health Canada PRCI Submission: Learnings and Perspectives from Argenx and Privacy Analytics
, 10:25amView SessionPANEL Outsource vs. Develop Internally: How are Sponsors Meeting Mounting Disclosure Requirements?
, 11:00amView Session